# A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

> **NCT06953934** · PHASE1 · NOT_YET_RECRUITING · sponsor: **AbbVie** · enrollment: 8 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-932

## Key facts

- **NCT ID:** NCT06953934
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-14
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06953934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06953934, "A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06953934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*